Overall Survival Was Defined as Time From Surgery to Death From Any Cause or Last Follow-up, Progression-free Survival Was Defined From Date of Surgery to Disease Progression Post-surgery or Death or Last Follow-up
Conditions
Brief summary
This is a large non-interventional observational bidirectional study planned to collect clinically relevant data and prognostic follow-up information of patients with cervical cancer who were seen at our center from 2010.01.01 to the end of this study.
Detailed description
This study is a large-scale observational, bi-directional analytical study, which collects clinical data from patients with cervical cancer who have received treatment in the Department of Gynecologic Oncology of the First Hospital Affiliated to the University of Science and Technology of China (Anhui Provincial Hospital), including age, weight, BMI, menopausal status, history of the current disease, past history, specialized examinations, results of tests, results of genetic testing, pathology-related data, and information related to surgery, etc. The diagnosis, subsequent treatment, and follow-up of the subjects follow the routine clinical procedures of the clinical center. The diagnosis and subsequent treatment and follow-up of the subjects followed the routine clinical procedures of the clinical center, and the follow-up data of the enrolled patients were collected every six months: imaging, tumor markers, recurrence and treatment. And clinical big data analysis. Therefore, patients who meet the enrollment criteria can be included, and the sample size is based on the actual number of cases included.
Interventions
None listed
Sponsors
Anhui Provincial Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Age ≥ 18 years; 2. patients with a clear pathological diagnosis of cervical cancer; 3. all patients included in this study were diagnosed after 1 January 2010 4. Diagnosis or treatment of cervical cancer at the centres covered by this study; 5. exemption from informed consent or signing of an informed consent form.
Exclusion criteria
1. Loss of contact during the follow-up period for no apparent reason; 2. Discharged from the hospital for follow-up treatment at an outside institution with unknown treatment status; 3. The investigator considers the patient unsuitable for participation in this study; 4. cases where the clinical diagnosis is in doubt or unclear.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| progression-free survival | 5 years |
Secondary
| Measure | Time frame |
|---|---|
| overall survival | 5 years |
Countries
China
Outcome results
None listed